Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1983-05-16
1985-03-05
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 90, 544 92, A61K 31535, C07D49804
Patent
active
045030529
ABSTRACT:
1-Oxa-beta-lactam antibiotics of the formula ##STR1## are broad spectrum antibiotics especially useful in the treatment of infections attributable to the gram-negative microorganisms such as Pseudomonas or are intermediates to such antibiotics.
REFERENCES:
patent: 3669965 (1972-06-01), White
patent: 4125611 (1978-11-01), Yamada et al.
patent: 4160087 (1979-07-01), Yamada et al.
patent: 4198504 (1980-04-01), Naito et al.
patent: 4226866 (1980-10-01), Christensen et al.
patent: 4288590 (1981-09-01), Oka et al.
patent: 4347470 (1982-11-01), Watanabe et al.
patent: 4352801 (1982-10-01), Nomoto et al.
patent: 4368198 (1983-01-01), Yamada et al.
Derwent Abstract 87992D of Japanese Unexamined Pat. No. J5 6131-592, (Bristol Banyo KK), Mar. 18, 1980.
Derwent Abstract 33812E of Japanese Unexamined Pat. No. J5 7046-990, (Fujimoto Seiyaku KK), Sep. 3, 1980.
Eli Lilly and Company
Harrison Nancy J.
Raymond Richard L.
Whale Arthur R.
LandOfFree
7-(2-(Substituted cinnolinoyl)amino)acetamido)-1-oxa-beta-lactam does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-(2-(Substituted cinnolinoyl)amino)acetamido)-1-oxa-beta-lactam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-(2-(Substituted cinnolinoyl)amino)acetamido)-1-oxa-beta-lactam will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1734129